FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023228035> ?p ?o ?g. }

• W2023228035 endingPage "2011" @default.
• W2023228035 startingPage "2011" @default.
• W2023228035 abstract "Abstract The genomic heterogeneity of HNSCC presents a major obstacle to broadly effective targeted therapy. We and others previously reported genomic mutational profiles of over 100 HNSCC tumors. To date, there has been a major translational gap between genomic findings and patient treatment selection in HNSCC. Mitogenic pathways are vital to cancer development and progression. Genetic mutations in mitogenic pathways have been shown to result in pathway activation, increased proliferation of tumor cells, and increased sensitivity to agents targeting the specific pathway. Here, we performed a bioinformatics analysis of 151 HNSCC to examine the mutational profiles of major mitogenic pathways previously shown to be important in HNSCC tumor biology, including MAPK, JAK/STAT and PI3K, and found that the PI3K pathway is the most frequently mutated mitogenic pathway (30.46% cases; 46/151 tumors) followed by JAK/STAT and MAPK, (9.27% cases; 14/151 tumors) and (7.95% cases; 12/151 tumors), respectively. HNSCC tumors with mutations in PI3K harbored 2.3 times more non-synonymous mutations (165.50 ± 24.08 vs 72.05 ± 6.63 mutations, P&lt;0.0001) and twice as many cancer gene mutations than the HNSCC tumors without any PI3K pathway mutations (7.15 ± 0.75 vs 3.56 ± 0.29 mutations, P&lt;0.0001), including multiple mutational events of genes in the PI3K pathway, suggesting that PI3K pathway mutations may promote the expansion of HNSCC tumor cells that are already genetically unstable. Interestingly however, in a small subset of HPV-positive HNSCC tumors (3 out of 45), PIK3CA was the only cancer gene found to be mutated, suggesting that the PI3K pathway alone may be sufficient to drive some HPV-positive HNSCC. The observed frequency of PIK3CA mutation in our 151 HNSCC cohort (12.58%; 19 mutations total) is higher than that reported previously in other smoking-related cancers such as lung cancer and esophageal cancer, where the respective PIK3CA mutation rates are not greater than 3-5%, suggesting a likely enrichment of PIK3CA mutations in HNSCC. Other components of the PI3K pathway were mutated in &lt;2 - 3.97% of HNSCC tumors sequenced. Major downstream effectors of the PI3K pathway, including PDK1, AKT1 were not mutated, while AKT2 and mTOR were mutated in just 1.29% (2 mutations) of HNSCC tumors. Importantly, PIK3CA and the PI3K pathway are currently targetable in human cancers, with several agents in various stages of clinical development. The growth of HNSCC xenografts derived from a cell line with a PIK3CA(H1047R) mutation, treated with the mTOR/PI3K inhibitor BEZ-235, was significantly inhibited. These findings suggest that PIK3CA, and potentially other PI3K pathway, mutations may serve as predictive biomarkers in HNSCC to guide treatment selection. Citation Format: Matthew L. Hedberg, Vivian Lui, Hua Li, Bhavana Vangara, Kelsey Pendleton, Yan Zeng, Breean Gilbert, Maria Freilino, Sam Sauerwein, Noah Peyser, Brenda Diergaarde, Peter Hammerman, Levi Garraway, Gordon Mills, Jennifer Grandis. The PI3K pathway is the most frequently mutated mitogenic pathway in HNSCC. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2011. doi:10.1158/1538-7445.AM2013-2011" @default.
• W2023228035 created "2016-06-24" @default.
• W2023228035 creator A5004171995 @default.
• W2023228035 creator A5005221518 @default.
• W2023228035 creator A5006760066 @default.
• W2023228035 creator A5015307563 @default.
• W2023228035 creator A5015532170 @default.
• W2023228035 creator A5017521861 @default.
• W2023228035 creator A5027568311 @default.
• W2023228035 creator A5029099095 @default.
• W2023228035 creator A5030464329 @default.
• W2023228035 creator A5055048393 @default.
• W2023228035 creator A5066404631 @default.
• W2023228035 creator A5075259283 @default.
• W2023228035 creator A5084819547 @default.
• W2023228035 creator A5088224394 @default.
• W2023228035 creator A5088286120 @default.
• W2023228035 date "2013-04-01" @default.
• W2023228035 modified "2023-10-16" @default.
• W2023228035 title "Abstract 2011: The PI3K pathway is the most frequently mutated mitogenic pathway in HNSCC." @default.
• W2023228035 doi "https://doi.org/10.1158/1538-7445.am2013-2011" @default.
• W2023228035 hasPublicationYear "2013" @default.
• W2023228035 type Work @default.
• W2023228035 sameAs 2023228035 @default.
• W2023228035 citedByCount "1" @default.
• W2023228035 countsByYear W20232280352021 @default.
• W2023228035 crossrefType "journal-article" @default.
• W2023228035 hasAuthorship W2023228035A5004171995 @default.
• W2023228035 hasAuthorship W2023228035A5005221518 @default.
• W2023228035 hasAuthorship W2023228035A5006760066 @default.
• W2023228035 hasAuthorship W2023228035A5015307563 @default.
• W2023228035 hasAuthorship W2023228035A5015532170 @default.
• W2023228035 hasAuthorship W2023228035A5017521861 @default.
• W2023228035 hasAuthorship W2023228035A5027568311 @default.
• W2023228035 hasAuthorship W2023228035A5029099095 @default.
• W2023228035 hasAuthorship W2023228035A5030464329 @default.
• W2023228035 hasAuthorship W2023228035A5055048393 @default.
• W2023228035 hasAuthorship W2023228035A5066404631 @default.
• W2023228035 hasAuthorship W2023228035A5075259283 @default.
• W2023228035 hasAuthorship W2023228035A5084819547 @default.
• W2023228035 hasAuthorship W2023228035A5088224394 @default.
• W2023228035 hasAuthorship W2023228035A5088286120 @default.
• W2023228035 hasConcept C104317684 @default.
• W2023228035 hasConcept C121608353 @default.
• W2023228035 hasConcept C501734568 @default.
• W2023228035 hasConcept C502942594 @default.
• W2023228035 hasConcept C54355233 @default.
• W2023228035 hasConcept C57074206 @default.
• W2023228035 hasConcept C62478195 @default.
• W2023228035 hasConcept C86554907 @default.
• W2023228035 hasConcept C86803240 @default.
• W2023228035 hasConceptScore W2023228035C104317684 @default.
• W2023228035 hasConceptScore W2023228035C121608353 @default.
• W2023228035 hasConceptScore W2023228035C501734568 @default.
• W2023228035 hasConceptScore W2023228035C502942594 @default.
• W2023228035 hasConceptScore W2023228035C54355233 @default.
• W2023228035 hasConceptScore W2023228035C57074206 @default.
• W2023228035 hasConceptScore W2023228035C62478195 @default.
• W2023228035 hasConceptScore W2023228035C86554907 @default.
• W2023228035 hasConceptScore W2023228035C86803240 @default.
• W2023228035 hasIssue "8_Supplement" @default.
• W2023228035 hasLocation W20232280351 @default.
• W2023228035 hasOpenAccess W2023228035 @default.
• W2023228035 hasPrimaryLocation W20232280351 @default.
• W2023228035 hasRelatedWork W2024936926 @default.
• W2023228035 hasRelatedWork W2088874644 @default.
• W2023228035 hasRelatedWork W2089605820 @default.
• W2023228035 hasRelatedWork W2095479222 @default.
• W2023228035 hasRelatedWork W2145454786 @default.
• W2023228035 hasRelatedWork W2618892274 @default.
• W2023228035 hasRelatedWork W2793191825 @default.
• W2023228035 hasRelatedWork W2958505263 @default.
• W2023228035 hasRelatedWork W4310603292 @default.
• W2023228035 hasRelatedWork W4361817057 @default.
• W2023228035 hasVolume "73" @default.
• W2023228035 isParatext "false" @default.
• W2023228035 isRetracted "false" @default.
• W2023228035 magId "2023228035" @default.
• W2023228035 workType "article" @default.